Patents by Inventor Mona DHALIWAL

Mona DHALIWAL has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10335376
    Abstract: The present invention relates to a capsule composition of raloxifene comprising multiparticulates comprising a) a core comprising raloxifene, and b) a taste-masking coating present in amount of from about 0.5% to about 50% w/w based on the core weight.
    Type: Grant
    Filed: July 31, 2018
    Date of Patent: July 2, 2019
    Assignee: Sun Pharmaceutical Industries Limited
    Inventors: Ujjwal Ranjan, Mona Dhaliwal, Mukesh Kumar Garg
  • Publication number: 20180333364
    Abstract: The present invention relates to a capsule composition of raloxifene comprising multiparticulates comprising a) a core comprising raloxifene, and b) a taste-masking coating present in amount of from about 0.5% to about 50% w/w based on the core weight.
    Type: Application
    Filed: July 31, 2018
    Publication date: November 22, 2018
    Inventors: Ujjwal Ranjan, Mona Dhaliwal, Mukesh Kumar Garg
  • Patent number: 10092522
    Abstract: The present invention relates to a capsule composition of raloxifene comprising multiparticulates, comprising a) a core comprising raloxifene; and b) a taste-masking coating present in an amount of from about 15% to about 80% w/w based on the total weight of the composition.
    Type: Grant
    Filed: December 12, 2017
    Date of Patent: October 9, 2018
    Assignee: Sun Pharmaceutical Industries, Ltd.
    Inventors: Ujjwal Ranjan, Mona Dhaliwal, Mukesh K. Garg
  • Publication number: 20180098943
    Abstract: The present invention relates to a capsule composition of raloxifene comprising multiparticulates comprising a) a core comprising raloxifene, and b) a taste-masking coating present in amount of from about 0.5% to about 50% w/w based on the core weight.
    Type: Application
    Filed: December 12, 2017
    Publication date: April 12, 2018
    Inventors: Ujjwal Ranjan, Mona Dhaliwal, Mukesh K. Garg
  • Patent number: 9872838
    Abstract: The present invention relates to a capsule composition of raloxifene comprising multiparticulates comprising a) a core comprising raloxifene, and b) a taste-masking coating present in amount of from about 0.5% to about 50% w/w based on the core weight.
    Type: Grant
    Filed: May 30, 2017
    Date of Patent: January 23, 2018
    Inventors: Ujjwal Ranjan, Mona Dhaliwal, Mukesh Kumar Garg
  • Publication number: 20170340573
    Abstract: The present invention relates to a capsule composition of raloxifene comprising multiparticulates comprising a) a core comprising raloxifene, and b) a taste-masking coating present in amount of from about 0.5% to about 50% w/w based on the core weight.
    Type: Application
    Filed: May 30, 2017
    Publication date: November 30, 2017
    Inventors: Ujjwal RANJAN, Mona DHALIWAL, Mukesh Kumar GARG
  • Publication number: 20170312223
    Abstract: The present invention relates to a sprinkle composition of cinacalcet which provides a dissolution profile which is comparable to the currently marketed tablet dosage form.
    Type: Application
    Filed: May 2, 2017
    Publication date: November 2, 2017
    Inventors: Avaneesh YADAV, Mona DHALIWAL, Mukesh Kumar GARG
  • Publication number: 20110236494
    Abstract: The present invention relates to oral taste masked pharmaceutical composition comprising ciprofloxacin or salts or esters thereof. It further relates to processes of preparing it.
    Type: Application
    Filed: February 25, 2011
    Publication date: September 29, 2011
    Applicant: RANBAXY LABORATORIES LIMITED
    Inventors: Sumit Kumar SAHA, Mona DHALIWAL, Swati AGGRAWAL, Mukesh Kumar GARG, Ajay Kumar SINGLA
  • Publication number: 20080268049
    Abstract: The technical field of the invention relates to stable solid dosage forms of amlodipine besylate and benazepril hydrochloride; and processes for their preparation. In particular, the solid dosage forms having reduced levels of 3-ethyl methyl [(2-aminoethoxy)methyl](2-chlorophenyl)methylpyridine-3,5 dicarboxylate (“impurity D”) and total impurities when free of dicalcium phosphate.
    Type: Application
    Filed: February 10, 2006
    Publication date: October 30, 2008
    Inventors: Mona Dhaliwal, V.V. Ram Mohan Rao, Vishnubhotla Nagaprasad
  • Publication number: 20080187561
    Abstract: The present invention relates to enteric coated didanosine compositions having a subcoat comprising hydroxypropyl methylcellulose, and process for preparation thereof. The enteric coating ranges from 19-25% w/w of the composition. The compositions are stable and have acceptable acid resistance and release profile.
    Type: Application
    Filed: December 21, 2007
    Publication date: August 7, 2008
    Inventors: Mona DHALIWAL, Girish Karanth, Romi Barat Singh